Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Galderma S.A.

Headquarters: France
Website: N/A
Year Founded: 1981
Status: Acquired

BioCentury | Nov 10, 2023
Management Tracks

New CFO, CMO at TreeFrog

Plus: Metagenomi names Borges CSO and Wapnick CFO, and updates from Teva, Century, Assembly and more
BioCentury | Apr 25, 2023
Management Tracks

Sanofi’s Silvestri joins Ipsen as CMO

Plus: Malier leaving Kurma and updates from Harmony, ImmunoGen, Tarsus and more
BioCentury | Mar 16, 2023
Finance

With $30M from Medicxi, Aldena aims to bring siRNA to dermatology

Typically more focused on asset-centric investing, VC backs platform play with programs moving toward clinic next year
BioCentury | Jan 20, 2022
Management Tracks

GSK’s Thirsk joins Bavarian Nordic as COO

Plus Baroldi, Bastings join Ionis, and updates from Exscientia, 
BioCentury | May 2, 2018
Distillery Techniques

Drug delivery

BioCentury | Dec 30, 2016
Company News

Bioventus, Galderma deal

BioCentury | Aug 8, 2016
Clinical News

Dysport abobotulinumtoxinA regulatory update

BioCentury | Aug 1, 2016
Company News

Chugai, Galderma deal

BioCentury | Jul 18, 2016
Clinical News

Adapalene 0 regulatory update

Items per page:
1 - 10 of 165